Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/160991
Full metadata record
DC FieldValueLanguage
dc.creatorSoraia Filipa Tavares Pinto
dc.date.accessioned2025-11-05T11:33:25Z-
dc.date.available2025-11-05T11:33:25Z-
dc.date.issued2024-07-24
dc.date.submitted2024-08-12
dc.identifier.othersigarra:682041
dc.identifier.urihttps://hdl.handle.net/10216/160991-
dc.language.isoeng
dc.rightsopenAccess
dc.subjectCiências biológicas
dc.subjectBiological sciences
dc.titleOral delivery of semaglutide through multifunctional FCRN-peptide targeting nanoparticles for treatment of type 2 diabetes mellitus
dc.typeTese
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.doi10.34626/zjrr-cm36
dc.identifier.tid101648995
dc.subject.fosCiências exactas e naturais::Ciências biológicas
dc.subject.fosNatural sciences::Biological sciences
thesis.degree.disciplinePrograma Doutoral em Ciências Biomédicas
thesis.degree.grantorInstituto de Ciências Biomédicas Abel Salazar
thesis.degree.grantorUniversidade do Porto
thesis.degree.level2
rcaap.embargofctartigos científicos
Appears in Collections:ICBAS - Tese

Files in This Item:
File Description SizeFormat 
682041.pdfOral delivery of semaglutide through multifunctional FCRN-peptide targeting nanoparticles for treatment of type 2 diabetes mellitus8.7 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.